Max Healthcare Institute has entered into a partnership with genomics biotech firm Anuva to conduct genomic-based research on various communicable and non-communicable diseases in India. The two partners have signed a Memorandum of Understanding (MoU) for a five-year engagement.
The objective of the research will be to identify insights for precision medicine application across diseases including breast cancer, lung cancer, diabetes, cardiac disease, kidney disease, drug resistant tuberculosis, and others. Under the collaboration, Max Healthcare will provide its expertise in clinical research and will serve as the clinical centre for data and/or sample collection from individuals who consent to share their data for the purpose of research.
Max Healthcare Institute offers healthcare services through its various facilities in Delhi and the National Capital Region, and facilities in Mohali and Bathinda.
Company Name | CMP |
---|---|
Aster DM Healthcare | 337.30 |
Apollo Hospital Ent. | 5915.80 |
Max Healthcare Inst | 820.95 |
Narayana Hrudayalay | 1192.00 |
Global Health | 1115.00 |
View more.. |